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Out in the Green: Biologically Active 
 Metabolites Produced by Cyanobacteria
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Abstract: Dried cyanobacteria (‘Spirulina’) are sold as a nutraceutical for their high content of proteins, essential 
fatty acids and vitamins. Beyond spirulina, other genera of cyanobacteria produce interesting small molecules 
that could find use in nutraceutical or pharmaceutical applications. This account presents recent research efforts 
on antimalarial nostocarboline and the aerucyclamides, as well as on potent toxins such as cyanopeptolin 1020 
and microcystins. Combinations of spectroscopic, computational, chemical and biological studies investigated 
the mechanism of action of these compounds. Their application potential with regard to nutraceuticals or phar-
maceuticals is discussed.
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Cyanobacteria (formerly called blue-green 
algae) are prokaryotic photoautotrophs 
that have been suggested to be present 
on earth for the past 2.5 billion years.[1] 
They populate a large variety of different 
habitats all over the globe, demonstrating 
their great ability for adaption. In addi-
tion, these primary producers are under 
constant ecological pressure from grazers 
(insects and crustaceans), competing pho-
totrophs, fungi and bacteria. Therefore, a 
large portion of the cyanobacterial genome 
is devoted to the production of biologically 
active small molecules (natural products, 
‘secondary metabolites’).[2] Some strains 
produce over twenty different compounds, 
and major structural classes such as pep-
tides, polyketides, terpenes, alkaloids, 
lipids and carbohydrates have been iso-
lated from these sources.[3a–f] In addition, 
these prokaryotic organisms are amenable 
to  genetic modification, and thus higher 
yields could be obtained through such ap-
proaches. 
Since ancient times, cyanobacteria 
have been consumed directly as microbial 
food in at least two locations separated by 
over 10000 km, i.e. in central America and 
in Northern Central Africa.[3g] This well-
documented tradition reaches well in the 
21st century, as ‘spirulina’ is currently sold 
in e.g. Europe and the US as a nutraceuti-
cal and marketed for its ingredients. While 
‘spirulina’ encompasses several genera 
and species, in general, these are charac-
terized by high protein content, as well as 
containing essential fatty acids and vita-
mins. One potential problem arises from 
the biotechnological production of ‘spi-
rulina’, as contamination by other cyano-
bacteria potentially producing toxins has 
to be considered. In this account, I will 
discuss our recent efforts to identify ad-
ditional toxins from cyanobacteria and to 
elucidate their mechanism of action. In ad-
dition, other cyanobacteria than ‘spirulina’ 
could provide benefits to human nutrition 
and health, and therefore, another part of 
this account is devoted to our recent efforts 
towards the isolation, structural character-
ization and chemical and biological stud-
ies of biologically active compounds from 
cyanobacteria with respect to potential 
nutraceutical or pharmaceutical applica-
tions. The interested reader is also referred 
to the original publications and the refer-
ences cited therein as documented in the 
bibliography.
In collaboration with the group of Prof. 
Dr. Jüttner at the Limnological Station of 
the University of Zurich, we became en-
gaged in spectroscopic and chemical stud-
ies of nostocarboline (1, Fig. 1), isolated 
from the freshwater cyanobacterium Nos-
toc 78-12a.[4] Nostocarboline (1) is a so-
called anhydronium base, a term coined 
by Robinson[5] for zwitterionic compounds 
exemplified by the resonance structures 2a 
and 2b. While the initial proof for structure 
was given by total synthesis,[4] we were 
later able to crystallize the nostocarboline 
anhydronium base from a MeOH/Et
2
O/
hexane mixture and determine its X-ray 
crystal structure.[6] Interestingly, nostocar-
boline is a chlorinated carbolinium alka-
loid found in a cyanobacterium originally 
isolated from a freshwater pond and cul-
tured in freshwater medium. The source of 
halogen and the mechanism of halogena-
tion[7] remain unclear.
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pounds via ribosomal peptide synthesis.[18] 
First identified by Schmidt and coworkers 
and Jaspers and coworkers for related cy-
clopeptides,[19] it was shown that a hyper-
variable cassette encoding for the primary 
sequence of the cyclamide is flanked by 
processing enzymes responsible for tai-
loring this precursor peptide into the final 
metabolite via macrocylization, heterocy-
clization and oxidation (and even possibly 
epimerization).[18] Dittmann and cowork-
ers established the genetic basis of the 
biosynthesis for the microcyclamides[20] 
(= aerucyclamides) but their prediction of 
chemical structure from genetic data led 
to a misassignment of structure for micro-
cyclamide 7806A that was later corrected 
based on chemical, physical and spectro-
scopic data.[17a]
The aerucyclamides are active against 
P. falciparum: The most active compound 
is aerucyclamide B (6) with a determined 
IC
50
 value of 0.7 mM and large selectivity 
(120 mM against L6 rat myoblasts).[17a] 
Surprisingly, saturation of one double 
bond to give the thiazoline-containing 
aerucyclamide A (5) resulted in a tenfold 
loss of activity. The other aerucyclamides 
C and D also show single digit IC
50 
val-
ues against P. falciparum with very little 
toxicity to rat myoblasts. Interestingly, 
aerucyclamide C (7) was the most active 
compound in this series against Trypano-
soma brucei rhodesiense STIB 900, the 
parasite causing African sleeping sick-
ness, with an IC
50
 value of 9.2 mM.[17a] 
These values were in line with earlier 
studies by Gerwick and coworkers on dif-
ferent cyclamides, the venturamides.[21] 
While the above examples highlight the 
potential of cyanobacteria for the discovery 
of potential pharmaceutical agents, many 
strains of cyanobacteria contain vicious 
Initial biological studies focussed on 
nostocarboline (1) as inhibitor of butyryl- 
and acetylcholinesterase,[4,8] a target which 
is addressed by currently used drugs such 
as galanthamine in early stages of Alz-
heimer’s disease.[9] Similar biological po-
tency was found for both nostocarboline 
and galanthamine in enzyme assays.[4,8] 
Regarding the potential ecological role of 
nostocarboline (1), two different possibili-
ties were evaluated: Either a function as a 
deterrent against grazers such as crusta-
ceans could be possible, or this compound 
could be acting as an allelochemical against 
competing phototrophs. The first possi-
bility was examined, and although some 
trypsin inhibition could be determined,[8] 
the toxicity of nostocarboline against the 
sensitive freshwater crustacean Thamno-
cephalus platyrus was found to be very 
weak.[8] The allelochemical activity as an 
algicide acting against competing photo-
trophs was studied next,[10] and strong ac-
tivity against both prokaryotic and eukary-
otic phototrophs could be demonstrated. 
A structure–activity relationship study 
demonstrated that the positively charged 
methyl carbolinium was found to be im-
portant for activity.[10] The mechanism of 
action was studied using chlorophyll-a 
fluorescence imaging in tobacco leaves, 
and it was demonstrated that a decrease 
in photosynthesis precedes cell death.[11] 
Algicidal compounds that do not show 
significant ecotoxity against crustaceans 
(or toxicity in general) are also interest-
ing for a completely different application: 
The malaria parasite Plasmodium falci-
parum contains an organelle of algal (or 
cyanobacterial descent): the apicoplast.[12] 
Targeting this apicoplast with selective 
herbicidal or algicidal compounds has 
been suggested to constitute a viable ap-
proach for the development of new active 
compounds against malaria.[13] We have 
shown that nostocarboline is active against 
P. falciparum, while displaying only little 
toxicity against rat myoblasts.[14] A series 
of SAR studies were conducted,[6] which 
resulted in the following conclusions: i) 
Replacing the N-Me group by larger sub-
stituents decreased antiplasmodial activity 
while increasing cytotoxicity; ii) dimeric 
structures linked via N(2) displayed very 
good inhibitory (18 nM for dimer 3) activ-
ity with large selectivity (SI >2500); iii) the 
bromo analogues such as 4 (related to the 
eudistomin series) retain or even show bet-
ter in vitro activity against P. falciparum.[6] 
We have also tested several compounds 
in the Plasmodium berghei mouse model, 
and a 50% reduction of parasitaemia vs 
untreated control group was observed af-
ter 4 × 50 mg/kg dosing.[6] These studies 
suggest nostocarboline (1) as interesting 
structure for further study as an antima-
larial agent.[15] 
We have also investigated the precur-
sor-directed biosynthesis of nostocarbo-
line derivatives in Nostoc 78-12A.[11] This 
research problem constituted a significant 
challenge for several reasons: i) being 
photoautotrophs, the uptake of xenobi-
otic chemicals is heavily regulated and in 
many cases difficult to carry out in cyano-
bacteria; ii) the generation of phytotoxic 
metabolites in a phototroph is difficult; iii) 
the promiscuity of the enzymes involved 
in the biosynthesis is difficult to predict a 
priori. As a consequence, there are only a 
few studies demonstrating the potential of 
precursor-directed biosynthesis in cyano-
bacteria.[16] We were able to feed several 
modified tryptophan precursors and to iso-
late fluorinated or methylated derivatives, 
which are difficult to access syntheti- 
cally, in yields up to 1.2 mg/L of culture 
medium.[11]
In addition to nostocarboline, we have 
investigated other antiplasmodial com-
pounds, the aerucyclamides A–D isolated 
from the cyanobacterium Microcystis 
aeruginosa PCC 7806.[17] The aerucycla-
mides are members of a large class of mac-
rocyclic hexapeptides (the cyclamides) 
featuring thiazole, thiazoline, oxazole and 
oxazoline rings complemented by hydro-
phobic amino acids. Whereas aerucycla-
mide A (5, Fig. 2) features a thiazoline 
ring, aerucyclamide B (6) represents the 
thiazole derivative, and consequently, cy-
clamide 6 can be prepared via chemical ox-
idation from compound 5. Aerucyclamide 
C (7) contains an oxazole ring instead of a 
thiazole, and Val and Ala instead of Ile and 
Gly amino acid residues. The last deriva-
tive 8 features Phe, Met and Gly as acyclic 
amino acids. The large variation of amino 
acids on this cyclic template stems from 
the interesting biosynthesis of these com-
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surface modification. In line with our hy-
pothesis, the anachelin chromophore was 
an efficient anchor to functionalize metal 
oxide surfaces,[33] and several applications 
such as the generation of protein resistant 
surfaces[33,34] or antimicrobial surfaces[35] 
have been realized. Key to the efficient 
binding of the anachelin chromophore is 
likely to reside in the presence of the am-
monium group, which modulates the pKa 
value of the hydroxy groups and protects 
the catechol from facile oxidation.[36] Sec-
ond generation analogs have been devel-
oped[36,37] and in particular the nitrodo-
pamine residue[36,38] is a readily available 
and efficient anchor for surface function-
alization.[36] The nitrodopamine anchor has 
been utilized by us and others for a vari-
ety of different applications ranging from 
drug delivery to nanoparticle functional-
ization.[36,38,39]
The last example highlights an im-
portant role of modern natural products 
chemistry. Studying all the different as-
pects of an iron chelator natural product 
led to completely a different application 
as an anchor used in surface functional-
ization. It is therefore of great importance 
to investigate all the different aspects of a 
natural product, from its biological origin, 
its physical and chemical properties to its 
biological applications, in order to uncover 
the many secrets of these natural treasures.
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toxins that have caused many incidents of 
poisoning to livestock and even humans.[3a] 
Therefore, research on cyanobacterial tox-
ins with regard to water quality and water 
supply still constitutes an important line of 
research, and in particular as recently more 
outbreaks of toxin-producing cyanobacte-
ria have been observed. The major class of 
toxins, which have been heavily studied 
over the last decades, are the microcystins, 
prominent hapatotoxins from cyanobacte-
ria.[3a,3f] In a collaboration with scientists 
from Austria, Uganda, the United States, 
Switzerland and Japan, we have been ac-
tive in the determination of new microcys-
tin variants from both European lakes and 
freshwater bodies of Uganda. For example, 
we have characterized a didehydrobutyrate 
microcystin 9 (Fig. 3) containing two ho-
mo tyrosine units,[22] a rare amino acid of 
which the biosynthesis has not been fully 
elucidated. Other new microcystin variants 
have been characterized by MS experi-
ments from Uganda freshwater bodies,[23] 
which are distinctly different from micro-
cystins observed in European or American 
lakes. 
Since large efforts of the research 
community were dedicated to understand-
ing microcystin toxicity in Microcystis, 
the perception arose in some studies that 
microcystin is the only toxin present in 
Microcystis. This invalid conclusion is of 
potential harm, as microcystin detection 
kits are a major assay for cyanobacterial 
toxicity. We have demonstrated that the 
structurally unrelated cyanopeptolin 1020 
(10) is also a toxin found in Microcystis 
UV-006.[24] This peptide is a member of the 
cyanopeptolin class of natural products, 
featuring a hydroxypiperidone residue as a 
key structural motif. We have determined 
very potent inhibitory activity of this pep-
tide against a series of serine proteases, 
and IC
50
 values as low as 670 pM against 
trypsin have been found.[24] In addition, a 
range of other serine proteases such as fac-
tor XIa (3.9 nM) and kallikrein (4.5 nM) 
are strongly inhibited by depsipeptide 10, 
thus rendering cyanopeptolin 1020 (10) 
a ‘dirty’ protease inhibitor. We have also 
determined a LC
50
 value against Thamno-
cephalus platyurus of 8.8 mM, which is in 
the same range as some of the well-known 
microcystins.[24] These values thus render 
the cyanopeptolins a potential second class 
of toxins in Microcystis, which might hold 
true for other species as well.[25]
Natural products can also provide 
structural inspiration for the identifica-
tion of molecular strategies unrelated to 
the presumed biological purpose of the 
parent compound. For example, we have 
analyzed a cyanobacterial siderophore and 
delineated key features for the generation 
of a molecular platform for surface modi-
fication. The cyanobacterial siderophore 
anachelin, isolated first by Budzikiewicz 
and coworkers[26] and independently by 
Itou et al.,[27] from the cyanobacterium 
Anabaena cylindrica displays an interest-
ing structure merging different structural 
subunits such as an alkaloid part, a peptide 
fragment and a polyketide. We have inves-
tigated the total synthesis and configura-
tion of anachelin,[28] its biogenesis[29] and 
its mechanism of action as an iron che-
lator.[30] The latter property proved to be 
interesting, as earlier studies both from 
surface chemistry and geochemistry sug-
gested that siderophores are able to bind 
to surfaces.[31] In addition, the catecholate 
fragment of anachelin resembles struc-
tural units of mussel adhesive proteins.[32] 
Therefore, we set out to test whether the 
anachelin chromophore can be used for 
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